The measurement of indirect costs in the health economics evaluation literature. A review (Q40829084)

24 September 2017

1 reference

title

The measurement of indirect costs in the health economics evaluation literature. A review (English)

1 reference

24 September 2017

Jacobs P

1

1 reference

PubMed ID

9885468

24 September 2017

Fassbender K

series ordinal

2

1 reference

24 September 2017

1 January 1998

1 reference

International Journal of Technology Assessment in Health Care

24 September 2017

1 reference

24 September 2017

14

1 reference

24 September 2017

4

1 reference

24 September 2017

799-808

1 reference

Costs, effects and cost-effectiveness analysis of a mobile maternal health care service in West Kiang, The Gambia.

24 September 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

A cost utility analysis of treatment options for gallstone disease: methodological issues and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

Episodic versus prophylactic infusions for hemophilia A: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

A cost-minimization analysis of laparoscopic cholecystectomy versus open cholecystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

Economic comparison of a tissue adhesive and suturing in the repair of pediatric facial lacerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

Treatment costs in Hodgkin's disease: a cost-utility analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

Cost effectiveness and equity of a community based cardiovascular disease prevention programme in Norsjö, Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

The friction cost method for measuring indirect costs of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

Indirect costs in economic studies: confronting the confusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

Cost-effectiveness of substance disorder interventions for people with severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

Cost-effectiveness analysis in early detection of prostate cancer: an evaluation of six screening strategies in a randomly selected population of 2,400 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

An economic evaluation of a clinical trial to compare automated percutaneous lumbar discectomy with microdiscectomy in the treatment of contained lumbar disc herniation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

7 January 2021

Indirect cost in economic evaluation: the opportunity cost of unpaid inputs

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

7 January 2021

A Markov process analysis comparing the cost effectiveness of maintenance therapy with citalopram versus standard therapy in major depression

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

7 January 2021

Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

7 January 2021

Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

7 January 2021

Cost-effectiveness of a routine varicella vaccination program for US children

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

7 January 2021

Towards a new approach for estimating indirect costs of disease

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

7 January 2021

A practical guide for calculating indirect costs of disease

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

7 January 2021

Estimating the indirect cost of illness: an assessment of the forgone earnings approach

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

7 January 2021

Avoiding double-counting in pharmacoeconomic studies

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

7 January 2021

Cost-effectiveness analysis of antiemetic therapy for ambulatory surgery

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

7 January 2021

Cost saving of 5-day therapy with cefpodoxime proxetil versus standard 10-day beta-lactam therapy for recurrent pharyngotonsillitis in adults. A prospective general practice study

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

7 January 2021

An economic analysis of strategies for the use of contrast media for diagnostic cardiac catheterization

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

7 January 2021

Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

7 January 2021

In- and out-patient rehabilitation in rheumatoid arthritis. A controlled, open, longitudinal, cost-effectiveness study

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

7 January 2021

Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

7 January 2021

Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300012095

7 January 2021

10.1017/S0266462300012095

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

9885468